Type
. Recombinant cytokines for controlling mycobacterial infections. Trends in microbiology. 1995;3(1):22-7.
Type
. [A very current aspect of the fate of infectious diseases: tuberculosis, leprosy and opportunistic mycobacteria]. Bulletin de l'Academie nationale de medecine. 1995;179(4):805-20; discussion 820-2.
Type
. Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies. American journal of respiratory and critical care medicine. 1995;151(4):1083-6.
Type
. Tuberculosis control in resource-poor countries: alternative approaches in the era of HIV. Lancet (London, England). 1995;346(8976):675-7.
Type
. HLA and mycobacterial infection: increased frequency of B8 in Japanese leprosy. Tissue antigens. 1978;11(1):61-4.
Type
. Glycoside-bearing liposomal delivery systems against macrophage-associated disorders involving Mycobacterium leprae and Mycobacterium tuberculosis. Indian journal of biochemistry & biophysics. 1995;32(3):147-51.
Type
. Concomitant occurrence of leprosy and tuberculosis: leprosy vaccine, a myth or reality?. Leprosy review [Internet]. 1995;66(2):179-81. Available from: http://leprev.ilsl.br/pdfs/1995/v66n2/pdf/v66n2a11.pdf
Type
. Testing for antibody to human immunodeficiency virus type 1 in a population in which mycobacterial diseases are endemic. The Journal of infectious diseases. 1995;172(2):543-6.
Type
. Epidemiological aspects and implications of the disappearance of leprosy from Norway; some factors contributing to the decline. Leprosy review [Internet]. 1981;52 Suppl 1:147-65. Available from: http://leprev.ilsl.br/pdfs/1981/v52s1/pdf/v52s1a16.pdf
Type
. The effect of delayed addition of antigen and 'E' rosetting on the proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal individuals or from patients with tuberculosis or leprosy. Immunology. 1981;44(3):585-91.